HIV and co‐infections
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Summary: Despite significant reductions in morbidity and mortality secondary to availability of effective combination anti‐retroviral therapy (cART), human immunodeficiency virus (HIV) infection still accounts for 1.5 million deaths annually. The majority of deaths occur in sub‐S aharan A frica where rates of opportunistic co‐infections are disproportionately high. In this review, we discuss the immunopathogenesis of five common infections that cause significant morbidity in HIV‐infected patients globally. These include co‐infection withM ycobacterium tuberculosis,C ryptococcus neoformans, hepatitis B virus, hepatitis C virus, andP lasmodium falciparum. Specifically, we review the natural history of each co‐infection in the setting of HIV, the specific immune defects induced by HIV, the effects of cART on the immune response to the co‐infection, the pathogenesis of immune restoration disease (IRD) associated with each infection, and advances in the areas of prevention of each co‐infection via vaccination. Finally, we discuss the opportunities and gaps in knowledge for future research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
Brahmer, J. R., Tykodi, S. S., Chow, L. Q. M., Hwu, W.-J., Topalian, S. L., Hwu, P., Drake, C. G., Camacho, L. H., Kauh, J., Odunsi, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200694 · Cited by 7,945 · cited 1×
“Blockade of PD-1 in vitro reversed CD8 T-cell exhaustion (168), suggesting that novel PD-1 or PD1-ligand-1 (PDL-1) antibodies currently being trialed in the clinic for cancer (169, 170) may potentially be a useful adjunct therapy in improving the HBV-specific T-cell response in HIV-HBV coinfected patients on HBV-activ…”
BackgroundMicrobial translocation is a cause of systemic immune activation in chronic HIV infection
Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., et al. (2006) · Nature Medicine · doi:10.1038/nm1511 · Cited by 3,559
Natural history of liver fibrosis progression in patients with chronic hepatitis C
Poynard, T., Bedossa, P., & Opolon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07642-8 · Cited by 3,011 · cited 2×
“In those with chronic HCV infection, HIV or HBV co-infection as well as increasing age and heavy alcohol use all contribute to an accelerated progression to cirrhosis (234, 247, 248).”
BackgroundGlobal epidemiology of hepatitis C virus infection
Shepard, C. W., Finelli, L., & Alter, M. J. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70216-4 · Cited by 2,758
Pathogenesis of Liver Fibrosis
Hernandez-Gea, V., & Friedman, S. L. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130246 · Cited by 1,809
Marcellin, P., Gane, E., Buti, M., Afdhal, N., Sievert, W., Jacobson, I. M., Washington, M. K., Germanidis, G., Flaherty, J. F., Schall, R. A., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61425-1 · Cited by 1,788
Global malaria mortality between 1980 and 2010: a systematic analysis
Murray, C. J., Rosenfeld, L. C., Lim, S. S., Andrews, K. G., Foreman, K. J., Haring, D., Fullman, N., Naghavi, M., Lozano, R., & Lopez, A. D. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60034-8 · Cited by 1,452 · cited 1×
“falciparum infection continues to cause more than 1 million deaths each year (282).”
BackgroundExtracting a cellular hierarchy from high-dimensional cytometry data with SPADE
Qiu, P., Simonds, E. F., Bendall, S. C., Gibbs, K. D., Bruggner, R. V., Linderman, M. D., Sachs, K., Nolan, G. P., & Plevritis, S. K. (2011) · Nature Biotechnology · doi:10.1038/nbt.1991 · Cited by 956 · cited 1×
“The application of powerful novel technologies such as systems biology (343) or systems immunology (344), mass flow cytometry techniques which enable simultaneous measurement of multiple parameters in a single cell, and novel analysis platforms such as spanning-tree progression analysis of density-normalized events an…”
BackgroundFirst Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children
The RTS, S. C. T. P. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102287 · Cited by 896
A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants
The RTS, S. C. T. P. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1208394 · Cited by 752
Evidence for the Involvement of VAR2CSA in Pregnancy-associated Malaria
Salanti, A., Dahlbäck, M., Turner, L., Nielsen, M. A., Barfod, L., Magistrado, P., Jensen, A. T. R., Lavstsen, T., Ofori, M. F., Marsh, K., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041579 · Cited by 604
Sandler, N. G., Koh, C., Roque, A., Eccleston, J. L., Siegel, R. B., Demino, M., Kleiner, D. E., Deeks, S. G., Liang, T. J., Heller, T., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.063 · Cited by 307 · cited 2×
“However, other studies have not shown an association between circulating LPS and liver disease in HBV, HCV, or HIV-HCV co-infection, but they have showed an association with sCD14 (154, 155).”
BackgroundResultRicke, C. H., Staalsoe, T., Koram, K., Akanmori, B. D., Riley, E. M., Theander, T. G., & Hviid, L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3309 · Cited by 303
Jarvis, J. N., Meintjes, G., Rebe, K., Williams, G. N., Bicanic, T., Williams, A., Schutz, C., Bekker, L.-G., Wood, R., & Harrison, T. S. (2012) · AIDS · doi:10.1097/qad.0b013e3283536a93 · Cited by 290
Staalsoe, T., Shulman, C. E., Bulmer, J. N., Kawuondo, K., Marsh, K., & Hviid, L. (2004) · The Lancet · doi:10.1016/s0140-6736(03)15386-x · Cited by 288
Duffy, P. E., & Fried, M. (2003) · Infection and Immunity · doi:10.1128/iai.71.11.6620-6623.2003 · Cited by 260 · cited 2×
“Attempts to correlate function of anti-VAR2CSA antibodies with protection from malaria disease have revealed that the ability of serum or purified IgG from pregnant women in malaria endemic areas to block adhesion of infected erythrocytes to chondroitin sulfate A also increases with increasing numbers of pregnancies (…”
BackgroundMethodBreaking down the barrier: The effects of HIV-1 on the blood–brain barrier
Strazza, M., Pirrone, V., Wigdahl, B., & Nonnemacher, M. R. (2011) · Brain Research · doi:10.1016/j.brainres.2011.05.015 · Cited by 218
Recombinant Interferon‐γ1b as Adjunctive Therapy for AIDS‐Related Acute Cryptococcal Meningitis
Pappas, P. G., Bustamante, B., Ticona, E., Hamill, R. J., Johnson, P. C., Reboli, A., Aberg, J., Hasbun, R., & Hsu, H. H. (2004) · The Journal of Infectious Diseases · doi:10.1086/420829 · Cited by 202
Immune reconstitution inflammatory syndrome: the trouble with immunity when you had none
Barber, D. L., Andrade, B. B., Sereti, I., & Sher, A. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2712 · Cited by 169 · cited 1×
“(50) have proposed a model of TB-IRIS in which CD4 T-cell depletion results in the failure of macrophage activation and accumulation of mycobacteria-laden macrophages, which become activated after cART is commenced due to an increase in IFN-c-producing CD4 T cells, leading to the excessive production of IL-6 and TNF-a.”
BackgroundSuguitan, Jr., Leke, R. G. F., Fouda, G., Zhou, A., Thuita, L., Metenou, S., Fogako, J., Megnekou, R., & Taylor, D. W. (2003) · The Journal of Infectious Diseases · doi:10.1086/378500 · Cited by 161 · cited 2×
“Placental leukocytes from malaria-infected women are enriched for monocytes, and higher levels of proinflammatory cytokine and chemokine secretion by placental leukocytes were associated with the proportion of monocytes, suggesting these cells are an important source of proinflammatory cytokines (300).”
BackgroundStaalsoe, T., Megnekou, R., Fievét, N., Ricke, C. H., Zornig, H. D., Leke, R., Taylor, D. W., Deloron, P., & Hviid, L. (2001) · The Journal of Infectious Diseases · doi:10.1086/322809 · Cited by 161 · cited 1×
“Development of anti-VAR2CSA antibodies mainly occurs in the second trimester of pregnancy and increases with the number of pregnancies (289, 290, 311, 312).”
BackgroundO'Neil-Dunne, I., Achur, R. N., Agbor-Enoh, S. T., Valiyaveettil, M., Naik, R. S., Ockenhouse, C. F., Zhou, A., Megnekou, R., Leke, R., Taylor, D. W., et al. (2001) · Infection and Immunity · doi:10.1128/iai.69.12.7487-7492.2001 · Cited by 156
Feng, G., Aitken, E., Yosaatmadja, F., Kalilani, L., Meshnick, S. R., Jaworowski, A., Simpson, J. A., & Rogerson, S. J. (2009) · The Journal of Infectious Diseases · doi:10.1086/599841 · Cited by 69 · cited 1×
“This requires use of assays to measure induction of protective antibody function such as opsonization (315, 318, 342) and inhibition of CSA binding (314) to determine optimum immune responses.”
MethodSelf-citation
Cited by
COVID-19 Among People Living with HIV: A Systematic Review
Mirzaei, H., McFarland, W., Karamouzian, M., & Sharifi, H. (2021) · AIDS and Behavior · doi:10.1007/s10461-020-02983-2 · Cited by 260
A Call to Arms: Quest for a Cryptococcal Vaccine
Caballero Van Dyke, M. C., & Wormley, F. L. (2018) · Trends in Microbiology · doi:10.1016/j.tim.2017.10.002 · Cited by 61
Metadata
- Authors
- Chang, C. C., Crane, M., Zhou, J., Mina, M., Post, J. J., Cameron, B. A., Lloyd, A. R., Jaworowski, A., French, M. A., & Lewin, S. R.
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 2013-06-16
- Volume
- 254
- Issue
- 1
- Pages
- 114-142
- ISSN
- 0105-2896 (ISSN-L)
- 1600-065X
- OpenAlex
- W2130330017
- Cited by
- 163
- References
- 24
- FWCI
- 1.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.